[MCEMENT] QoQ TTM Result on 31-Dec-2011 [#4]

Stock
[MCEMENT] MALAYAN CEMENT BERHAD
Announcement Date
22-Feb-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Dec-2011 [#4]
Profit Trend
QoQ- 13.12%
YoY- 7.62%
Quarter Report
Latest QR
Upcoming QR
MCEMENT's Result
MCEMENT's Financial Summary
View:
Show?
TTM Result
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Revenue 2,706,767 2,623,539 2,593,991 2,552,564 2,512,897 2,455,461 2,379,239 8.95%
PBT 475,336 439,193 432,899 414,647 364,963 369,891 357,227 20.91%
Tax -113,818 -102,375 -101,245 -97,000 -86,105 -72,953 -62,536 48.90%
NP 361,518 336,818 331,654 317,647 278,858 296,938 294,691 14.55%
-
NP to SH 360,667 335,597 330,699 317,845 280,972 300,818 299,247 13.21%
-
Tax Rate 23.94% 23.31% 23.39% 23.39% 23.59% 19.72% 17.51% -
Total Cost 2,345,249 2,286,721 2,262,337 2,234,917 2,234,039 2,158,523 2,084,548 8.14%
-
Net Worth 3,135,374 3,101,386 3,092,889 3,113,280 3,064,288 3,053,867 3,058,091 1.67%
Dividend
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Div 288,989 288,920 288,808 288,979 288,667 288,909 289,022 -0.00%
Div Payout % 80.13% 86.09% 87.33% 90.92% 102.74% 96.04% 96.58% -
Equity
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Net Worth 3,135,374 3,101,386 3,092,889 3,113,280 3,064,288 3,053,867 3,058,091 1.67%
NOSH 849,695 849,695 849,695 850,623 848,833 848,296 851,836 -0.16%
Ratio Analysis
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
NP Margin 13.36% 12.84% 12.79% 12.44% 11.10% 12.09% 12.39% -
ROE 11.50% 10.82% 10.69% 10.21% 9.17% 9.85% 9.79% -
Per Share
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 318.56 308.76 305.28 300.08 296.04 289.46 279.31 9.13%
EPS 42.45 39.50 38.92 37.37 33.10 35.46 35.13 13.40%
DPS 34.00 34.00 34.00 34.00 34.00 34.00 34.00 0.00%
NAPS 3.69 3.65 3.64 3.66 3.61 3.60 3.59 1.84%
Adjusted Per Share Value based on latest NOSH - 850,623
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 202.38 196.16 193.95 190.85 187.89 183.59 177.89 8.95%
EPS 26.97 25.09 24.73 23.76 21.01 22.49 22.37 13.23%
DPS 21.61 21.60 21.59 21.61 21.58 21.60 21.61 0.00%
NAPS 2.3443 2.3189 2.3125 2.3277 2.2911 2.2833 2.2865 1.67%
Price Multiplier on Financial Quarter End Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 -
Price 8.90 7.30 7.20 7.00 6.56 7.45 7.40 -
P/RPS 2.79 2.36 2.36 2.33 2.22 2.57 2.65 3.48%
P/EPS 20.97 18.48 18.50 18.73 19.82 21.01 21.06 -0.28%
EY 4.77 5.41 5.41 5.34 5.05 4.76 4.75 0.27%
DY 3.82 4.66 4.72 4.86 5.18 4.56 4.59 -11.49%
P/NAPS 2.41 2.00 1.98 1.91 1.82 2.07 2.06 10.99%
Price Multiplier on Announcement Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 22/11/12 28/08/12 29/05/12 22/02/12 22/11/11 24/08/11 24/05/11 -
Price 9.62 8.60 7.07 7.37 6.59 7.01 7.47 -
P/RPS 3.02 2.79 2.32 2.46 2.23 2.42 2.67 8.53%
P/EPS 22.66 21.77 18.17 19.72 19.91 19.77 21.26 4.33%
EY 4.41 4.59 5.50 5.07 5.02 5.06 4.70 -4.14%
DY 3.53 3.95 4.81 4.61 5.16 4.85 4.55 -15.52%
P/NAPS 2.61 2.36 1.94 2.01 1.83 1.95 2.08 16.28%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment